Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0C6QQ
|
|||
Former ID |
DIB016758
|
|||
Drug Name |
Besipirdine
|
|||
Synonyms |
Besipirdine hydrochloride; HP-749; P86-7480
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7] | Phase 3 | [1] | |
Company |
Hoechst Marion Roussel Inc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H17N3
|
|||
Canonical SMILES |
CCCN(C1=CC=NC=C1)N2C=CC3=CC=CC=C32
|
|||
InChI |
1S/C16H17N3/c1-2-12-18(15-7-10-17-11-8-15)19-13-9-14-5-3-4-6-16(14)19/h3-11,13H,2,12H2,1H3
|
|||
InChIKey |
OTPPJICEBWOCKD-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 119257-34-0
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adrenergic receptor alpha-1A (ADRA1A) | Target Info | Antagonist | [2] |
KEGG Pathway | Calcium signaling pathway | |||
cGMP-PKG signaling pathway | ||||
Neuroactive ligand-receptor interaction | ||||
AMPK signaling pathway | ||||
Adrenergic signaling in cardiomyocytes | ||||
Vascular smooth muscle contraction | ||||
Salivary secretion | ||||
Panther Pathway | Alpha adrenergic receptor signaling pathway | |||
Reactome | Adrenoceptors | |||
G alpha (q) signalling events | ||||
G alpha (12/13) signalling events | ||||
WikiPathways | Monoamine GPCRs | |||
Calcium Regulation in the Cardiac Cell | ||||
GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
Endothelin Pathways | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
AMPK Signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of UroGene. | |||
REF 2 | Alpha-Adrenergic activity and cardiovascular effects of besipirdine HCl (HP 749) and metabolite P7480 in vitro and in the conscious rat and dog. J Pharmacol Exp Ther. 1997 Apr;281(1):337-46. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.